Experimental Preemptive Immunotherapy of Murine Cytomegalovirus Disease with CD8 T-Cell Lines Specific for ppM83 and pM84, the Two Homologs of Human Cytomegalovirus Tegument Protein ppUL83 (pp65)

CD8 T cells are the principal antiviral effectors controlling cytomegalovirus (CMV) infection. For human CMV, the virion tegument protein ppUL83 (pp65) has been identified as a source of immunodominant peptides and is regarded as a candidate for cytoimmunotherapy and vaccination. Two sequence homolo...

詳細記述

保存先:

書誌詳細
出版年:	J Virol
主要な著者:	Holtappels, Rafaela, Podlech, Jürgen, Grzimek, Natascha K. A., Thomas, Doris, Pahl-Seibert, Marcus-Folker, Reddehase, Matthias J.
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2001
主題:	Vaccines and Antiviral Agents
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC114382/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11413326/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.14.6584-6600.2001
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Experimental Preemptive Immunotherapy of Murine Cytomegalovirus Disease with CD8 T-Cell Lines Specific for ppM83 and pM84, the Two Homologs of Human Cytomegalovirus Tegument Protein ppUL83 (pp65)

類似資料